Burris H - Search Results

1

Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial.

Jerusalem G, de Boer RH, Hurvitz S, Yardley DA, Kovalenko E, Ejlertsen B, Blau S, Özgüroglu M, Landherr L, Ewertz M, Taran T, Fan J, Noel-Baron F, Louveau AL, Burris H. Jerusalem G, et al. Among authors: burris h. JAMA Oncol. 2018 Oct 1;4(10):1367-1374. doi: 10.1001/jamaoncol.2018.2262. JAMA Oncol. 2018. PMID: 29862411 Free PMC article. Clinical Trial.

2

Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer.

Burris HA 3rd, Hainsworth JD, Erland JB, Morrissey LH, Kalman LA, Hon JK, Scullin DC Jr, Smith SW, Greco FA. Burris HA 3rd, et al. Semin Oncol. 2000 Feb;27(1 Suppl 2):9-13. Semin Oncol. 2000. PMID: 10697030 Clinical Trial.

3

Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin.

Greco FA, Erland JB, Morrissey LH, Burris HA 3rd, Hermann RC, Steis R, Thompson D, Gray J, Hainsworth JD. Greco FA, et al. Among authors: burris ha 3rd. Ann Oncol. 2000 Feb;11(2):211-5. doi: 10.1023/a:1008369812295. Ann Oncol. 2000. PMID: 10761758 Free article. Clinical Trial.

4

Docetaxel (Taxotere) in HER-2-positive patients and in combination with trastuzumab (Herceptin).

Burris HA 3rd. Burris HA 3rd. Semin Oncol. 2000 Apr;27(2 Suppl 3):19-23. Semin Oncol. 2000. PMID: 10810934 Review.

5

Gemcitabine, paclitaxel, and carboplatin for advanced non-small-cell lung cancer.

Greco FA, Burris HA 3rd, Hainsworth JD. Greco FA, et al. Among authors: burris ha 3rd. Oncology (Williston Park). 2000 Jul;14(7 Suppl 4):31-4. Oncology (Williston Park). 2000. PMID: 10960943 Clinical Trial.

6

Docetaxel (Taxotere) plus trastuzumab (Herceptin) in breast cancer.

Burris HA 3rd. Burris HA 3rd. Semin Oncol. 2001 Feb;28(1 Suppl 3):38-44. doi: 10.1053/sonc.2001.22815. Semin Oncol. 2001. PMID: 11301373 Review.

7

Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.

Meluch AA, Greco FA, Burris HA 3rd, O'Rourke T, Ortega G, Steis RG, Morrissey LH, Johnson V, Hainsworth JD. Meluch AA, et al. Among authors: burris ha 3rd. J Clin Oncol. 2001 Jun 15;19(12):3018-24. doi: 10.1200/JCO.2001.19.12.3018. J Clin Oncol. 2001. PMID: 11408496 Clinical Trial.

8

Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.

Hainsworth JD, Burris HA 3rd, Greco FA. Hainsworth JD, et al. Among authors: burris ha 3rd. Semin Oncol. 2001 Jun;28(3 Suppl 9):21-5. Semin Oncol. 2001. PMID: 11441411 Review.

9

Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience.

Hainsworth JD, Burris HA 3rd, Greco FA. Hainsworth JD, et al. Among authors: burris ha 3rd. Semin Oncol. 2001 Apr;28(2 Suppl 4):43-7. Semin Oncol. 2001. PMID: 11479897 Review.

10

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial.

Hainsworth JD, Burris HA 3rd, Yardley DA, Bradof JE, Grimaldi M, Kalman LA, Sullivan T, Baker M, Erland JB, Greco FA. Hainsworth JD, et al. Among authors: burris ha 3rd. J Clin Oncol. 2001 Aug 1;19(15):3500-5. doi: 10.1200/JCO.2001.19.15.3500. J Clin Oncol. 2001. PMID: 11481356 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

623 results

Search Page

Filters